Mesh term Ipilimumab
Browse to parent terms:Antibodies, Monoclonal, Humanized
Description
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.Search for this term in our Faculty Database
View this term at the NCBI website
